03a: Cancer Flashcards
(61 cards)
Cell cycle: which checkpoint is that of “no return”?
G1/S
(X) cell cycle phase: cell synthesizes all of the proteins
necessary for mitosis.
X = G2
RTKs are bound by (X) and activate downstream signaling pathways.
X = growth factors
Cancer signaling: Elevated levels of Cyclin D (activate/inhibit) (X), which then do what?
Activate;
X = Cdk4/6 (cyclin-dep kinases)
Phosphorylate Rb, which then releases the E2F TFs
30% of all cancers have which mutated oncogene?
Ras
T/F: Cyclins are oncogenes.
True
T/F: Rb is an oncogene.
False - tumor suppressor
PTEN is a PI3K (stimulator/inhibitor). Which of these is an oncogene?
Inhibitor;
PI3K (oncogene)
and PTEN is tumor suppressor
T/F: AKT and mTOR are both oncogenes.
True
List endogenous factors that cause DNA damage/mutations.
- ROS (by metabolic products)
2. DNA replication
T/F: Only about 5% of all cancer driving mutations arise from normal mutation rates.
False - 66%!!!
Why do BRCA1/2 mutations predispose women to breast/ovarian cancers?
BRCA1/2 are important in DNA double strand break repair; inherited mutations in these lead to cancer predisposition
Aneuploidy refers to (X) chromosomes and occurs as a result of (Y) process.
X = abnormal (number/structure) Y = defects in mitosis
T/F: Normal cells mis-segregate one chromosome in every 100 divisions.
True
EGFR inhibitors target which special function of tumor cells?
Sustained proliferative signaling
Although many EGFR inhibitors are in trial, they’re all failing due to:
Developed resistance
Cyclin-dep kinase inhibitors target which special function of tumor cells?
Evading growth suppressors (ex: p53, Rb)
Why do Cyclin-dep kinase inhibitors fail as drugs?
Hard to target
T/F: Immunocompromised patients show higher tumor rates.
True - immune system detects and eliminates tumor cells
Aspirin (increases/decreases) risk of (X) cancer by 40%. Why?
Decreases
X = colon
Reduces inflammation (release of ROS and Cytokines)
VEGF signaling inhibitors target which special function of tumor cells?
Inducing angiogenesis
ITP: Most cases involve Ig(X) autoantibodies that target (Y).
X = G Y = platelet membrane glycoproteins IIb-IIIa
TTP and HUS: excessive (activation/inhibition) of platelets, which then do what?
Activation
deposit as thrombi in small blood vessel (causing microangiopathic hemolytic anemia)
Two major mechanisms that trigger DIC:
- Release of procoagulants (esp tissue factor) into circulation
- Widespread endothelial damage